论文部分内容阅读
【目的】比较紫杉醇与顺铂治疗中晚期子宫颈癌患者的疗效。【方法】选取在本院接受化疗的子宫颈癌患者80例，根据化疗药物不同分为紫杉醇组和顺铂组，比较两组患者的近期疗效（治疗有效率）和远期疗效（1年后、2年后、3年后的总生存率和无瘤生存率）。【结果】紫杉醇组的有效率为95．00％（38／40），显著高于顺铂组75．00（30／40），差异有统计学意义（P＜0．05）。紫杉醇组治疗1年后、2年后、3年后的总生存率和无瘤生存率均明显优于顺铂组（ P＜0．05）。【结论】紫杉醇对中晚期子宫颈癌患者的化疗效果明显优于顺铂，值得临床推广应用。“,”[Objective] To compare the efficacies of different synchronous chemotherapeutic schemes for cervi‐cal cancer patients .[Methods] A total of 80 cervical cancer patients were divided randomly into two groups of pa‐clitaxel and cisplatin .And the therapeutic efficacies of two groups were compared .[Results] The paclitaxel group was superior to cisplatin group in near and long‐term efficacies and adverse events .The effective rate was higher in paclitaxel group than that in cisplatin group (95 .00% ,38/40 vs 75 .00% ,30/40) .And the difference had statisti‐cal significance .At 1 ,2 and 3 years after treatment ,the rates of overall survival and tumor‐free survival for pacli‐taxel group in were markedly superior than those for cisplatin group ( P <0 .05) .[Conclusion] For locally ad‐vanced cervical cancer patients ,the chemotherapeutic efficacies of paclitaxel are superior to those of cisplatin .